Dr. Eric Berg's Instagram Fenbendazole Claim: What the Evidence Actually Shows

A viral Instagram post from Dr. Eric Berg, DC, makes a striking claim. It says a drug sold to deworm dogs has brought stage 4 cancer patients to complete remission, for about $5 a dose. The post argues no drug company will spend $100 million testing a cure that cheap. Its patent expired long ago. So there's no profit in it, the post says. It links to a free diet guide in his bio. A small disclaimer on the post notes one thing. Dr. Berg holds a Doctor of Chiropractic degree, not a medical degree.

View the original post

This is a version of a claim we've covered before, from a different messenger. See Mel Gibson's Fenbendazole Claim on Joe Rogan for that one. The "cheap generic drug the industry won't touch" idea comes up often enough to address directly.

What's real

Fenbendazole and mebendazole are related drugs, both in the benzimidazole family. Both have shown some anti-cancer activity in lab dishes and in animal studies. That early research is real. It hasn't been retracted. Mebendazole is a close relative. It's approved for human use, unlike fenbendazole. It has gone further too. A small 2022 randomized trial tested it in 40 people with metastatic colorectal cancer. It was published in the journal Life Sciences (Hegazy et al.). Adding mebendazole to standard chemo (bevacizumab plus FOLFOX4) showed anti-tumor activity. It also lowered a tumor-growth marker, compared with adding a placebo. That's a real, published, human result.

It's also true that a drug with an expired patent has no company positioned to fund it. A full clinical trial costs hundreds of millions of dollars. That's a genuine gap in how drug research gets funded. But a funding gap is not the same thing as proof the drug works.

What's missing

Here's what the post doesn't say. No human trial, published or done, has tested fenbendazole — the drug in the post, not mebendazole — against any cancer. As of 2026, the trials that exist are small and just starting. Most are in South Korea. Mebendazole's own human data is mixed, not all good news. Alongside the encouraging 2022 colorectal trial, a separate trial of mebendazole in glioblastoma (brain cancer) came back negative.

A "$5 a dose, complete remission" claim about specific patients isn't something we can check from a social media post. Stories like it can't rule out simpler explanations. Maybe standard treatment worked. Maybe the cancer was already responding. Maybe the timeline is remembered generously. Patients in these stories are often, though not always, still getting standard treatment at the same time. That makes it hard to credit one drug alone.

In May 2026, the American Society of Clinical Oncology (ASCO) put out a formal Clinical Notice. It recommends against using ivermectin or fenbendazole to treat cancer. That's true alone or alongside standard treatment, outside a registered clinical trial. ASCO's reasoning is simple: there's no strong, peer-reviewed proof either drug is safe or works against any human cancer. Using them anyway carries a real risk of toxicity and drug interactions, for no proven benefit.

What to do with this

If you or someone you love is thinking about fenbendazole, mebendazole, or any unapproved drug alongside cancer treatment, tell your care team before you start. This isn't about talking you out of it. Any drug can interact with chemo, radiation, or other medicines in ways that matter for your safety. That's true even for a drug sold over the counter or for pets. A viral post, however sincere, isn't a substitute for that talk.

Sources

• ASCO, Clinical Notice on ivermectin and fenbendazole for cancer treatment, issued May 2026: ASCO Connection
• Hegazy et al., "Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer," Life Sciences, 2022: PubMed
• National Cancer Institute, "Complementary and Alternative Medicine": cancer.gov
• Cancer Explained, "Mel Gibson's Fenbendazole Claim on Joe Rogan": /news/fenbendazole-mel-gibson-joe-rogan-claim-fact-check/

How this article was prepared

An AI-assisted editorial system helped prepare this page, using ASCO's published clinical notice, the peer-reviewed Hegazy et al. trial on PubMed, and National Cancer Institute guidance. No named medical reviewer has checked this page unless one is listed above.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.